Drug Repurposing: Dipeptidyl Peptidase IV (DPP4) Inhibitors as Potential Agents to Treat SARS-CoV-2 (2019-nCoV) Infection
- Supplementary File 1:
PDF-Document (PDF, 1201 KiB)
-
Externally hosted supplementary file 1
Doi: 10.21203/rs.3.rs-28134/v1
Link: https://assets.researchsquare.com/files/rs-28134/v1/Supplementaryinformation.pdf
Rao, P.P.N.; Pham, A.T.; Shakeri, A.; El Shatshat, A.; Zhao, Y.; Karuturi, R.C.; Hefny, A.A. Drug Repurposing: Dipeptidyl Peptidase IV (DPP4) Inhibitors as Potential Agents to Treat SARS-CoV-2 (2019-nCoV) Infection. Pharmaceuticals 2021, 14, 44. https://doi.org/10.3390/ph14010044
Rao PPN, Pham AT, Shakeri A, El Shatshat A, Zhao Y, Karuturi RC, Hefny AA. Drug Repurposing: Dipeptidyl Peptidase IV (DPP4) Inhibitors as Potential Agents to Treat SARS-CoV-2 (2019-nCoV) Infection. Pharmaceuticals. 2021; 14(1):44. https://doi.org/10.3390/ph14010044
Chicago/Turabian StyleRao, Praveen P.N., Amy T. Pham, Arash Shakeri, Amna El Shatshat, Yusheng Zhao, Rahul C. Karuturi, and Ahmed A. Hefny. 2021. "Drug Repurposing: Dipeptidyl Peptidase IV (DPP4) Inhibitors as Potential Agents to Treat SARS-CoV-2 (2019-nCoV) Infection" Pharmaceuticals 14, no. 1: 44. https://doi.org/10.3390/ph14010044


